Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China · Delayed Price · Currency is CNY 26.68
+0.08 (0.30%)
At close: Feb 6, 2026
SHA:600196 Revenue
Shanghai Fosun Pharmaceutical (Group) had revenue of 9.88B CNY in the quarter ending September 30, 2025, a decrease of -5.46%. This brings the company's revenue in the last twelve months to 39.55B, down -4.96% year-over-year. In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B, down -0.80%.
Revenue (ttm)
39.55B
Revenue Growth
-4.96%
P/S Ratio
1.66
Revenue / Employee
975.14K
Employees
40,234
Market Cap
65.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.07B | -332.34M | -0.80% |
| Dec 31, 2023 | 41.40B | -2.55B | -5.81% |
| Dec 31, 2022 | 43.95B | 4.94B | 12.66% |
| Dec 31, 2021 | 39.01B | 8.70B | 28.72% |
| Dec 31, 2020 | 30.31B | 1.72B | 6.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| China Resources Sanjiu Medical & Pharmaceutical | 29.86B |
| Humanwell Healthcare (Group) | 24.18B |
| Zhejiang NHU Company | 22.47B |
| Beijing Tongrentang | 18.09B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Dong-E-E-Jiao | 6.12B |
Shanghai Fosun Pharmaceutical (Group) News
- 15 days ago - China’s Fosun Pharma eyes spin-off listing of vaccine unit in hot Hong Kong IPO market - South China Morning Post
- 4 months ago - China’s ‘health silk road’ in Africa gets a boost with insulin, pharma projects - South China Morning Post
- 5 months ago - Fosun’s Henlius in talks with Johnson & Johnson, Roche on cancer drug - South China Morning Post
- 11 months ago - Shanghai Fosun Pharmaceutical reports FY results - Seeking Alpha
- 2 years ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 3 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
- 4 years ago - Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal - Seeking Alpha
- 5 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha